Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction
Launched by MINGFU WU · Jun 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different treatments for women who have problems with their pelvic floor, which can include issues like pelvic organ prolapse or weakened pelvic muscles after childbirth. The goal is to find out which rehabilitation methods work best for these conditions in Chinese women. Researchers will compare treatments like pelvic muscle training, biofeedback electrical stimulation, and magnetic stimulation to see which is most effective in improving muscle strength and relieving symptoms. They will also look into what factors might predict who is likely to develop pelvic floor dysfunction and how well they respond to treatment.
To be eligible for the study, participants need to be women who have experienced weakness in their pelvic floor muscles after giving birth or have mild to moderate pelvic organ prolapse. They must be willing to sign consent to join the study. Throughout the trial, participants will receive various rehabilitation therapies and will complete questionnaires to track their symptoms and muscle strength at different points during and after treatment. It's important to note that women with serious medical issues, certain psychiatric disorders, or specific health conditions may not be able to participate.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. knowledge of the study, voluntary enrolment in the study, and signing of informed consent;
- • 2. postpartum pelvic floor weakness (pelvic floor muscle strength less than grade 3), or mild to moderate pelvic organ prolapse (POP-Q staging less than stage III), or pelvic organ prolapse combined with dysfunction (bowel or bladder dysfunction).
- Exclusion Criteria:
- • 1. history of comorbid serious medical or surgical illness;
- • 2. comorbid psychiatric disorders;
- • 3. contraindications to electrical and magnetic stimulation such as implanted pacemakers;
- • 4. pelvic malignancy, acute genitourinary infection or vaginal bleeding, and genital tract malformation.
About Mingfu Wu
Mingfu Wu is a dedicated clinical trial sponsor with a focus on advancing medical research and innovation. Committed to improving patient outcomes, Mingfu Wu collaborates with leading healthcare professionals and institutions to conduct rigorous clinical trials across various therapeutic areas. With a strong emphasis on ethical practices and regulatory compliance, the organization strives to ensure the safety and efficacy of new treatments. By leveraging cutting-edge methodologies and fostering partnerships, Mingfu Wu aims to contribute significantly to the medical community and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Wuhan, Hubei, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported